J2323 HCPCS code: Injection, natalizumab, 1 mg
J2323 is the HCPCS Level II code for injection, natalizumab, 1 mg. In 2024 Medicare paid an average of $17.43 per service for J2323 across 3,371,659 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 300 per day on outpatient hospital claims. Medicare volume fell 22% from 2022 to 2024 (4,348,126 to 3,371,659 services). In 2024, about 1,243 clinicians billed Medicare for J2323 for 1,501 beneficiaries; New York, Florida, Texas accounted for 26% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2008-01-01 |
| Last action effective | 2008-01-01 |
Who bills J2323 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 1,243 |
| Medicare beneficiaries | 1,501 |
| States with claims | 31 |
| Share of services in top 3 states (New York, Florida, Texas) | 26% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J2323, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 4,348,126 | 1,985 | $21.81 | $17.40 |
| 2023 | 3,855,601 | 1,786 | $22.13 | $17.62 |
| 2024 | 3,371,659 | 1,501 | $21.89 | $17.43 |
States with the most J2323 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| New York | 331,509 | $16.79 |
| Florida | 302,714 | $17.48 |
| Texas | 227,401 | $17.48 |
| North Carolina | 219,620 | $17.67 |
| California | 219,609 | $17.24 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 300 | Prescribing Information |
| practitioner claims | 300 | Prescribing Information |
What changed for J2323
- 2008-01-01: J2323 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J2323?
J2323 is the HCPCS Level II code for injection, natalizumab, 1 mg. Short descriptor: "Natalizumab injection".
How much does Medicare pay for J2323?
In 2024, the average Medicare payment was $17.43 per service (average allowed $21.89).
Does Medicare cover J2323?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J2323 can be billed per day?
300 on outpatient hospital claims; 300 on practitioner claims (NCCI medically unlikely edits).
Related J23 codes
- J2300 — Injection, nalbuphine hydrochloride, per 10 mg
- J2305 — Injection, nitroglycerin, 5 mg
- J2310 — Injection, naloxone hydrochloride, per 1 mg
- J2311 — Injection, naloxone hydrochloride (zimhi), 1 mg
- J2312 — Injection, naloxone hydrochloride, not otherwise specified, 0.01 mg
- J2313 — Injection, naloxone hydrochloride (zimhi), 0.01 mg
- J2315 — Injection, naltrexone, depot form, 1 mg
- J2320 — Injection, nandrolone decanoate, up to 50 mg
- J2325 — Injection, nesiritide, 0.1 mg
- J2326 — Injection, nusinersen, 0.1 mg
- J2327 — Injection, risankizumab-rzaa, intravenous, 1 mg
- J2329 — Injection, ublituximab-xiiy, 1mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J2323
- Watch J2323 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J2323
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.